The experimental drug IC7Fc reduces artery-clogging fats and inflammation in mice, pointing to a potential new strategy for preventing heart disease. Earlier work linked the experimental drug ‘IC7Fc’ to improvements in type 2 diabetes, and new research now points to a possible role in cardiovascular health as well. Scientists report that the compound may lower […]
Source link